Tech Company Financing Transactions
CartiHeal Funding Round
On 2/1/2018, CartiHeal raised $2.5 million in funding from Bioventus.
Transaction Overview
Company Name
Announced On
2/1/2018
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
Bioventus (Tony Bihl)
Proceeds Purpose
The funding will focus on CartiHeal's ongoing Agili-C IDE clinical study. Further to the trial's initiation 3 months ago, over thirty patients were already enrolled, according to enrollment rate forecasts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
17 Atir Yeda St. 4th Floor
Kfar Saba, 4464313
Israel
Kfar Saba, 4464313
Israel
Phone
Website
Email Address
Overview
CartiHeal, a privately-held medical device company headquartered in Israel, develops proprietary implants for the treatment of cartilage and osteochondral defects in traumatic and osteoarthritic joints.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Nir Altschuler
VP - Operations
Amir Goren
Browse more venture capital transactions:
Prev: 2/1/2018: Juniper Square venture capital transaction
Next: 2/1/2018: Nuro venture capital transaction
Share this article
About Database of VC Transactions
We do our best to document every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs